Healio

FDA agrees to design of phase 2b/3 intermediate dry AMD clinical trial

Please provide your email address to receive an email when new articles are posted on . Allegro received agreement from the FDA under a special protocol assessment for the design of a phase 2b/3 ...
Business Insider

Allegro Ophthalmics Receives FDA Agreement Under Special Protocol Assessment (SPA) for Phase 2b/3 Clinical Trial of Risuteganib for the Treatment of Intermediate Dry AMD

- Mitochondrial Stabilizing CandidateRisuteganib Has Shown Best Corrected Visual Acuity Gains in Dry AMD Patient Population SAN JUAN CAPISTRANO, Calif., April 12, 2023 /PRNewswire/ -- Allegro ...
Nasdaq

Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics

Agreement Includes Global Rights for Risuteganib, An Investigational Treatment Expected to Help Reverse Vision Loss Due to Dry AMD, A Significant Unmet Medical Need LAVAL, QC and SAN JUAN CAPISTRANO, ...
The Globe and Mail

Intermediate AMD Market Offers High Commercial Potential as Patient Pool Expands and Innovation Accelerates | DelveInsight

The intermediate AMD treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, ...
Los Angeles Times

Dance review: Mark Morris Dance Group performs ‘L’Allegro’ with L.A. Opera

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. ‘L’Allegro, il Penseroso ed il Moderato,’ choreographer Mark Morris’ ...
Post-Bulletin

Allegro turns to 'Marushka' for holiday ballet

We're all addicted to a little Russian piece known as "The Nutcracker" at Christmas time. But Allegro School of Dance has something different from Russia to offer this holiday season: "Marushka and ...